CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH AN HDAC INHIBITOR
摘要
Described is a pharmaceutical composition comprising (a) a parvovirus and (b) a histone deacetylase inhibitor (HDACI) and the use of said composition for treatment of cancer, e.g., brain tumor, cervical carcinoma, or pancreatic carcinoma.